Post job

Nabriva Therapeutics CEO and executives

Executive Summary. Based on our data team's research, Theodore R. Schroeder is the Nabriva Therapeutics's CEO. Nabriva Therapeutics has 175 employees, of which 17 are in a leadership position.
Here are further demographic highlights of the leadership team:
  • The Nabriva Therapeutics executive team is 41% female and 59% male.
  • 68% of the management team is White.
  • 15% of Nabriva Therapeutics management is Hispanic or Latino.
  • 10% of the management team is Black or African American.
Work at Nabriva Therapeutics?
Share your experience

Rate Nabriva Therapeutics' leadership communication with employees.

Zippia waving zebra
Name & TitleBio
Theodore R. Schroeder

CEO

Cam Gallagher

Founder

Steven P. Gelone Pharm. D

President & COO

Colin Broom

CEO / President

Daniel Dolan

Chief Financial Officer

Carrie L. Bourdow

Board Member

Charles A. Rowland

Board Member

Christine Guico-Pabia

Chief Medical Officer

Daniel D. Burgess

Board Member

John Christopher Naftzger

Secretary & General Counsel

John Christopher Naftzger's LinkedIn

Do you work at Nabriva Therapeutics?

Does the leadership team provide a clear direction for Nabriva Therapeutics?

Nabriva Therapeutics jobs

Nabriva Therapeutics founders

Name & TitleBio
Theodore R. Schroeder

CEO

Cam Gallagher

Founder

Nabriva Therapeutics board members

Name & TitleBio
Theodore R. Schroeder

CEO

Steven P. Gelone Pharm. D

President & COO

Colin Broom

CEO / President

Carrie L. Bourdow

Board Member

Charles A. Rowland

Board Member

Daniel D. Burgess

Board Member

Lisa Dalton

Board Member

Mark H. N. Corrigan

Board Member

Stephen W. Webster

Board Member

Nabriva Therapeutics executives FAQs

Zippia gives an in-depth look into the details of Nabriva Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Nabriva Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Nabriva Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Nabriva Therapeutics. The data presented on this page does not represent the view of Nabriva Therapeutics and its employees or that of Zippia.

Nabriva Therapeutics may also be known as or be related to Nabriva Therapeutics plc,, Nabriva Therapeutics PLC and Nabriva Therapeutics.